Par Drugs & Chemicals Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2026 is 59.51% vs -33.16% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 454.12% vs -82.29% in Mar 2026

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 343.06% vs -76.24% in Mar 2026

Interest

QoQ Growth in quarter ended Jun 2026 is -50.00% vs 300.00% in Mar 2026

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Par Drugs & Che. With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

31.28

253.06

-221.78

-87.64%

Other Operating Income

0.00

Total Operating income

31.28

253.06

-221.78

-87.64%

Raw Material Cost

12.84

234.13

-221.29

-94.52%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.91

-26.07

26.98

103.49%

Employee Cost

1.69

8.99

-7.30

-81.20%

Power Cost

0.00

Manufacturing Expenses

-0.01

0.00

-0.01

Selling and Distribution Expenses

0.00

Other Expenses

9.47

32.24

-22.77

-70.63%

Total Expenditure (Excl Depreciation)

24.90

249.29

-224.39

-90.01%

Operating Profit (PBDIT) excl Other Income

6.38

3.77

2.61

69.23%

Other Income

0.94

0.57

0.37

64.91%

Operating Profit (PBDIT)

7.32

4.34

2.98

68.66%

Interest

0.02

0.00

0.02

Exceptional Items

0.00

Gross Profit (PBDT)

7.30

4.34

2.96

68.20%

Depreciation

0.96

1.44

-0.48

-33.33%

Profit Before Tax

6.33

2.91

3.42

117.53%

Tax

1.62

0.73

0.89

121.92%

Provisions and contingencies

0.00

Profit After Tax

4.71

2.17

2.54

117.05%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

4.71

2.17

2.54

117.05%

Equity Capital

12.30

8.88

3.42

38.51%

Face Value

10.00

0.00

Reserves

104.39

0.00

104.39

Earnings per share (EPS)

3.83

2.44

1.39

56.97%

Diluted Earnings per share

3.83

2.45

1.38

56.33%

Operating Profit Margin (Excl OI)

20.40%

1.49%

0.00

18.91%

Gross Profit Margin

23.34%

1.72%

0.00

21.62%

PAT Margin

15.06%

0.86%

0.00

14.20%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 31.28 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 59.51% vs -33.16% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 20.08% vs 15.21% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 4.71 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 454.12% vs -82.29% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 41.44% vs 31.62% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 6.38 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 343.06% vs -76.24% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 79.21% vs -16.04% in Jun 2025

Quarterly - Interest

Interest 0.02 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -50.00% vs 300.00% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 20.40%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025